Page 61 - 2014_AutumnSale

This is a SEO version of 2014_AutumnSale. Click here to view full version

« Previous Page Table of Contents Next Page »
Page 61
The Willner Window Product Reference Catalog, Autumn 2014
since 1911
• Willner Chemists •
the nutritional supplement professionals
NOW Foods
*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
NOWFOODS.COM / phone: 800-999-8069 / fax: 800-886-1045 / email: sales@nowfoods.com
Science Delivers
CLINICAL VALIDATION
In a randomized placebo-controlled clinical trial with 38 healthy middle-aged
volunteers (40-60 years old), supplementation with Longvida
®
(40 mg curcumin twice a
day for 4 weeks) resulted in statistically significant support of already normal very low
levels of circulating beta amyloid protein, as compared to pre-supplementation levels
(mean ± SEM, #p < 0.05). No difference was detected in the placebo group.
Nutr J. 2012; 11:79.
New CurcuBrain
from NOW
®
utilizes Longvida
®
, a superior form of curcumin that’s highly bioavailable and promotes rapid
absorption into the bloodstream and target tissues. CurcuBrain
has 400 mg of Longvida
®
, which delivers 80 mg of free curcumin
per serving. Free curcumin crosses the blood-brain barrier more easily than typical curcuminoids, where it supports cognitive
function as well as the body’s free radical defenses.*
• Free Curcumin Crosses the Blood-Brain Barrier*/ Superior Bioavailability*
• Supports Learning and Memory*/ Promotes Cognitive Health*
The Cognitive Power of CurcuBrain
WITH THE STRENGTH OF LONGVIDA
®
OPTIMIZED CURCUMIN
Effect of Longvida
®
Curcumin supplementation on the level of
ß
amyloid protein in healthy adult volunteers (mean ± SEM, # p < 0.05
as compared to baseline).